Foundation Medicine and Flatiron Health Announce First-of-its-Kind Integration of Genomic Profiling Into OncoEMR®
Oncology practices will now be able to order and track Foundation Medicine, Inc. s comprehensive genomic profiling (CGP) tests for their patients without leaving Flatiron Health s OncoEMR platform, the two companies announced today.
- Oncology practices will now be able to order and track Foundation Medicine, Inc. s comprehensive genomic profiling (CGP) tests for their patients without leaving Flatiron Health s OncoEMR platform, the two companies announced today.
- Clinicians increasingly rely on genomic insights to guide clinical decision-making, and Foundation Medicine is committed to implementing new solutions that enable widespread access to CGP, said Kathleen Kaa, Interim Chief Commercial Officer at Foundation Medicine.
- The integration of Foundation Medicine tests into OncoEMR, and other leading EMR systems to follow, is just one way were improving our offerings to fuel precision medicine for cancer patients.
- "We are excited to welcome Foundation Medicine in the first of our planned CGP integrations with OncoEMR, said James Hamrick, MD, MPH, Vice President, Clinical Oncology at Flatiron Health.